Background: Parotid gland malignancies are primarily treated by surgery. Particularly extensive tumor recurrences mostly require very large-scale and cosmetically unfavorable interventions. Unclear anatomic conditions often restrict the intraoperative orientation. This case report demonstrates the markedly improved quality of life achieved despite the complexity of the intervention.
A 62-year-old male patient presented with acute bleeding from a tumor in the right parotid gland. During the past few weeks, minor bleeding from the tumor region had occurred repeatedly but had always stopped. Primary irradiation had been performed for an inoperable mucoepidermoid carcinoma of the right parotid gland one and a half years ago.
Findings and Diagnostics
The ENT examination revealed an approximately 5 cm necrotic tumor crater in the right preauricular region that bled massively and was colonized with fly maggots. A right facial palsy of House-Brackmann Grade VI was also detected. The patient reported having had this since the initiation of radiation therapy one and a half years ago. After removing the maggots and inserting a Tabotamp gauze for temporary bleeding control (Fig. 1) , complete hemostasis was achieved by embolizing the anterior auricular branch of the right superficial temporal artery. Restaging disclosed the ulcerated tumor in the right parotid gland without skull base infiltration (cervical CT, Fig. 2 ) with ipsilateral lymph node *Address correspondence to this author at the ENT Department, Charité Campus Mitte, Universitätsmedizin Berlin, Chariteplatz 1, D-10117 Berlin, Germany; E-mail: oender.goektas@charite.de 
Therapy
Repeat irradiation with curative intent was not possible on consultation with the radiotherapists. An alternative was chemotherapy with palliative intention. After the remaining option of an operative intervention had been discussed in detail with the patient, the decision was made in favor of a surgical procedure. We then performed a radical tumor resection with a hemimandibulectomy, a resection of the auricle, auditory canal and middle ear, a mastoidectomy and a modified radical neck dissection on the right side. The diversification technique according to Stennert [1] was employed for microsurgical facial nerve reconstruction, using the ansa cervicalis for the buccal branch and autonomic nerve transposition with the cervical plexus for the ocular branch. The defect was closed by a pectoralis major myocutaneous flap after tumor-free marginal resection (Fig. 3) . The lagophthalmos was treated by pretarsal fixation of a platinum chain on the right side. Lower jaw reconstruction was not performed.
Clinical Course
Wound healing was uneventful (Fig. 4) . The histological examination showed a complete R0 resection of the previously diagnosed mucoepidermoid carcinoma (Fig. 5) . The patient was discharged in very good general condition and is undergoing short-interval follow-ups in our outpatient tumor consultation service. He had no complaints in terms of dizziness but a maximal conductive hearing loss due to complete occlusion of the auditory canal and middle ear. After tumor resection and primary healing, the patient received an adhesive ear epithesis to improve the aesthetic results (Fig. 6) . He has shown no signs of tumor recurrence over the 9 months that have elapsed thus far. He does not have lockjaw or mastication problems. If facial nerve palsy persists, complete eyelid closure can be achieved by using a platinum chain for lid loading. 
ASSESSMENT AND DISCUSSION
Together with adenoid cystic carcinomas, mucoepidermoid carcinomas are the most common malignant salivary gland tumors [2] . Both malignant growths can occur at any age [3, 4] . The etiology [5] is unknown. Chromosome translocation with the creation of fusion genes has recently been discussed in the literature [6] . A t translocation is thought to be present in about 60% of the mucoepidermoid carcinomas (11; 19) . Moreover, there have been case examples of a mucoepidermoid carcinoma developing after radioiodine therapy for primary thyroid carcinoma [7] . Mucoepidermoid carcinoma manifests in the parotid gland in about 50%. Histologically, this is a sharply demarcated tumor with both cystic and solid components. The neoplasms can be differentiated into low-grade types with predominantly cystic lesions, intermediate-grade types, and high-grade types with a predominantly solid growth pattern. According to the literature, this grading is prognostically relevant for mucoepidermoid carcinomas of the minor salivary glands and parotid glands [8] [9] [10] . Ipsilateral lymph node involvement is prognostically unfavorable [11] [12] . High-grade mucoepidermoid carcinomas have a particularly poor prognosis with a recurrence rate of 25% and a 10-year survival rate of less than 50% [13] [14] [15] .
Extensive recurrences of previously irradiated malignant salivary gland tumors are a therapeutic challenge. Apart from repeat radiotherapy (possibly combined with chemotherapy) or palliative chemotherapy, complex surgical procedures may basically also be performed. Surgical resection with curative intent is difficult and often leads to considerable quality-of-life impairment and a marked increase of possible peri-and postoperative complications. Since our patient had already been irradiated one and a half years ago, our radiotherapists rejected the option of repeat irradiation. Even neutron irradiation, which some authors favor for inoperable tumors [16] , was out of the question. After thoroughly informing the patient, we decided to perform a radical tumor resection including the external ear, auditory canal, mastoid and lower jaw. The defect was closed by a pectoralis major myocutaneous flap. The diversification technique described by Stennert [1] was used for microsurgical facial nerve reconstruction, and the paralytic lagophthalmos was treated by a platinum chain implant. In addition, an adhesive ear epithesis was fitted after primary healing. The patient refused the implantation of an epithesis anchor. The patient is having regular follow-ups and has been recurrence-free for 9 months. There has been no recovery of active facial nerve function up to now
CONCLUSION FOR CLINICAL PRACTICE
It is difficult to treat previously irradiated malignant salivary gland tumors. Apart from repeat irradiation or chemotherapy with palliative intent, there is the option of performing complex surgical procedures. The aim of surgery should be to resect the tumor as completely as possible and to enable a high postoperative quality of life. The possible interventions should be discussed in detail with the patients and integrated in an effective overall concept in order to minimize peri-and postoperative complications.
